Development of approaches to improve cell survival in myoblast transfer therapy.
about
Eccentric exercise facilitates mesenchymal stem cell appearance in skeletal muscleNS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosisSkeletal muscle stem cellsImaging Approaches in Functional Assessment of Implantable Myogenic Biomaterials and Engineered Muscle TissueStem cell therapy for incontinence: where are we now? What is the realistic potential?Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocksIsolation and immortalization of patient-derived cell lines from muscle biopsy for disease modelingCardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cellsDifferential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell TransplantationMurine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repairA role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency.Asymmetric self-renewal and commitment of satellite stem cells in muscle.Minimally invasive approach to the repair of injured skeletal muscle with a shape-memory scaffold.Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success.Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms.Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cellsSGNP: an essential Stress Granule/Nucleolar Protein potentially involved in 5.8s rRNA processing/transport.Defining the heterogeneity of skeletal muscle-derived side and main population cells isolated immediately ex vivo.Cell Therapy in Myology: Dynamics of Muscle Precursor Cell Death after Intramuscular Administration in Non-human PrimatesIntramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data.Satellite cells and the muscle stem cell nicheExpression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells.Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?A novel approach to collecting satellite cells from adult skeletal muscles on the basis of their stress tolerance.The role of stem cells in skeletal and cardiac muscle repair.The differential proliferative ability of satellite cells in Lantang and Landrace pigs.Muscle-derived stem cells.Problems and solutions in myoblast transfer therapy.Adenovirus mediated gene transfer to skeletal muscle.Muscle stem cells.Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness.Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx miceMicroencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy.Transplantation of muscle-derived stem cells into the corpus cavernosum restores erectile function in a rat model of cavernous nerve injury.Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.Biological approaches to improve skeletal muscle healing after injury and diseaseProspective isolation of skeletal muscle stem cells with a Pax7 reporterSystemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogsType II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscleHuman skeletal muscle cells with a slow adhesion rate after isolation and an enhanced stress resistance improve function of ischemic hearts.
P2860
Q21560888-244CC07B-E06D-4CF1-9B48-E88398416D0AQ24675340-2F08884A-7B62-419C-81E1-E46662A0B8BDQ24801042-8DF403F7-D2AF-49A5-838C-564BF7F95985Q26766438-FA70BC9B-2A5A-4D59-B6F6-29CC670F7D21Q26827498-041B3C8C-20E5-4AA9-874B-855B9BD6AB1CQ26828390-AD104C34-8FC8-48FD-AC0B-CD864F4F3C45Q27302912-CCD4B002-AC4B-4871-9C46-724C481DC3CBQ27303668-2E7F670D-A0E2-4A32-BD88-72836EFAF7E5Q27309883-47E6527A-F934-4F81-B54F-1C2CB6C22B79Q28741359-301B9930-E366-47D3-B410-F650C2889339Q30480421-AFE1CEE4-2FB1-4481-B1C3-E0B35476C89FQ30489194-179A3CAA-A089-47A4-9838-7F33F3E0E06AQ30650943-D6F74A95-3636-4D4B-A304-75C0BB32715FQ31150057-24525D13-1624-4218-8A97-F196ADC4101AQ33193766-3EDE4093-BCFA-43D4-9B4A-E94DEB544708Q33198739-B12B2A7A-50FB-4716-9525-AC59ACB3B699Q33384126-17F63FE6-41BE-4C9C-A66B-D8A05F5C0305Q33519613-9FC9F1AE-BF50-4617-BC6D-B80D98EA6C17Q33735831-BDE7E4CF-0E6C-42DE-8B00-EDE784D7A42BQ33785188-0C38F6F1-73B0-4CC4-BD0B-D15762773031Q33816665-383404F9-7335-4BA0-914E-9DF500F00A56Q33928516-99861EDC-585E-4328-93A7-9C80F47C19BCQ33947773-FF275D2A-4258-4C8C-AC6F-70CB7C8487D8Q34037111-A13604E8-0D14-4177-871B-C3B5A857395FQ34124836-725A003C-76A4-4EE1-86EE-793E6BFF022BQ34199906-8E8B5711-962A-4419-9CB1-EA9C3F385A5AQ34658455-B1B4D68E-44E0-4664-9749-BCF8F15B9A8CQ34687663-8105D6F9-095F-4166-BB6D-157B739B3200Q34733229-D39DBD6B-9375-4B79-8C13-10D817F3D26AQ34736845-9BAF1E11-958B-477F-8859-45B860FF6835Q34769510-5201EBB6-DF6E-4735-9687-60E1F583181DQ34973330-F4F803DF-5550-4BC5-BD8E-6C93A11FCCBBQ35003611-897A9069-A59E-4590-AB25-10DBCA601C26Q35019624-1EAD4145-3550-4580-A071-36ECEC72EB69Q35087066-4DFD72BC-5AC1-4CCE-AF36-B6E6A3BB567EQ35180158-B777F92D-539F-45F8-AE8E-C60128029CB1Q35213447-95C16189-2F25-43CB-A78C-D6910AFFBC47Q35475301-97214568-FE73-45F2-A19E-DE5CC4136667Q35543635-D4255BE7-800A-47D5-82D9-0EE932A9DAF4Q35665159-61745E18-F9B6-43CE-B4E7-73BB6DBE9AFE
P2860
Development of approaches to improve cell survival in myoblast transfer therapy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Development of approaches to improve cell survival in myoblast transfer therapy.
@ast
Development of approaches to improve cell survival in myoblast transfer therapy.
@en
type
label
Development of approaches to improve cell survival in myoblast transfer therapy.
@ast
Development of approaches to improve cell survival in myoblast transfer therapy.
@en
prefLabel
Development of approaches to improve cell survival in myoblast transfer therapy.
@ast
Development of approaches to improve cell survival in myoblast transfer therapy.
@en
P2093
P2860
P356
P1476
Development of approaches to improve cell survival in myoblast transfer therapy.
@en
P2093
P2860
P304
P356
10.1083/JCB.142.5.1257
P407
P577
1998-09-01T00:00:00Z